Table 5 Type of studies eligible for inclusion in the systematic review recommended by each study
From: Recommendations to conduct and report systematic reviews in medical literature: a scoping review
Type of studies | N (%) |
|---|---|
Any | 52 (62.7%) |
RCT | 6 (7.2%) |
Diagnostic test studies | 6 (7.2%) |
Clinical trials | 3 (3.6%) |
Economic evaluations | 2 (2.4%) |
Diagnostic and prognostic studies | 2 (2.4%) |
Adverse events | 1 (1.2%) |
Anatomical studies | 1 (1.2%) |
Etiology studies | 1 (1.2%) |
Evidence on equity | 1 (1.2%) |
Medical tests, genetic tests, and prognostic tests | 1 (1.2%) |
Network meta-analysis | 1 (1.2%) |
Observational studies | 1 (1.2%) |
Observational studies reporting prevalence and cumulative incidence data | 1 (1.2%) |
Protocols | 1 (1.2%) |
RCT, observational studies, diagnostic testsa | 1 (1.2%) |
Studies of older people | 1 (1.2%) |
Validation studies | 1 (1.2%) |
Total | 83 (100%) |